VR

Venkateswara Rao Inaganti

Active Director Director DIN 03053973
DIN 03053973 First appointment Nov 2006 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2006
Shareholding value β€’β€’β€’β€’ Premium profile

About Venkateswara Rao Inaganti

Data last updated:

Venkateswara Rao Inaganti is a Director at Spt Pharmaceuticals Private Limited (since 2006). The company operates in Chemicals.

DIN 03053973
Primary Designation Director
Industry Chemicals
First Appointment 27 Nov 2006
Oldest Company Age 19 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Spt Pharmaceuticals Private Limited U24232TG2006PTC051795
Director27 Nov 20062006Active

Board colleagues of Venkateswara Rao Inaganti

NameDINCompanyDesignation
Rajani Inaganti03071966Spt Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Spt Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Venkateswara Rao Inaganti

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Venkateswara Rao Inaganti

Venkateswara Rao Inaganti currently holds 1 directorship: Spt Pharmaceuticals Private Limited (Director, since 27 Nov 2006).

Venkateswara Rao Inaganti was first appointed on 27 Nov 2006 as Director at Spt Pharmaceuticals Private Limited.

The current boards of Venkateswara Rao Inaganti's companies include Rajani Inaganti (Spt Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available